P
Protalix Biotherapeutics Inc
AMEX:PLX
Protalix Biotherapeutics Inc
AMEX:PLX
Price:
1.98
USD
-1%
Market Closed
Market Cap:
$159.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
U
|
United Insurance Holdings Corp
F:0UI
|
US |
|
Property Franchise Group PLC
LSE:TPFG
|
UK |
|
Koninklijke Ahold Delhaize NV
OTC:AHODF
|
NL |
|
S
|
Sempra
VSE:SREN
|
US |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
Indian Railway Finance Corp Ltd
NSE:IRFC
|
IN |
|
Loncin Motor Co Ltd
SSE:603766
|
CN |
|
Fortuna Silver Mines Inc
TSX:FVI
|
CA |
Wall St Price Targets
PLX Price Targets Summary
Protalix Biotherapeutics Inc
Protalix Biotherapeutics Inc
Wall Street analysts forecast PLX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
Lowest Forecast
Price Target
10.1
USD
410% Upside
Average Forecast
Price Target
11.22
USD
467% Upside
Highest Forecast
Price Target
12.6
USD
536% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PLX's stock price target?
Price Target
11.22
USD
11.22
USD
According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for Protalix Biotherapeutics Inc?
Projected CAGR
15%
15%
Over the last 14 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 2 years is 15%.
